Basics Tarsus Pharmaceuticals, Inc. Common Stock IPO Date: October 12, 2020 Sector: Healthcare Industry: Biotech Market Cap: $2.43B Activated in VL: True Average Daily Range Avg Daily Range: $0.75 | 2.73% Avg Daily Range (30 D): $0.95 | 1.99% Avg Daily Range (90 D): $0.88 | 1.95% Institutional Daily Volume Avg Daily Volume: .27M Avg Daily Volume (30 D): .56M Avg Daily Volume (90 D): .51M Trade Size Avg Trade Size (Sh.): 58 Avg Trade Size (Sh.) (30 D): 47 Avg Trade Size (Sh.) (90 D): 47 Institutional Trades Total Inst.Trades: 1,271 Avg Inst. Trade: $2.74M Avg Inst. Trade (30 D): $3.14M Avg Inst. Trade (90 D): $3.06M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.81M Avg Closing Trade (30 D): $3.77M Avg Closing Trade (90 D): $4.36M Avg Closing Volume: 78.37K     News Aug 27, 2025 @ 9:00 PM Tarsus to Participate in Upcoming Investor Confere... Source: Tarsus Pharmaceuticals, Inc. Aug 27, 2025 @ 8:26 AM 3 Biotech Catalysts Present Major Opportunity Source: Nathan Reiff Jul 30, 2025 @ 9:00 PM Tarsus to Report Second Quarter 2025 Financial Res... Source: Tarsus Pharmaceuticals, Inc. May 29, 2025 @ 9:00 PM Tarsus to Participate in Upcoming Investor Confere... Source: N/A May 5, 2025 @ 8:40 PM Elanco Animal Health Sells Xdemvy Royalties To Bla... Source: Vandana Singh Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.48 $-.64 $-.59 Diluted EPS $-.48 $-.64 $-.59 Revenue $ 102.66M $ 78.34M $ 66.41M Gross Profit $ $ $ Net Income / Loss $ -20.34M $ -25.12M $ -23.11M Operating Income / Loss $ -22.18M $ -26.28M $ -24.42M Cost of Revenue $ $ $ Net Cash Flow $ -79.14M $ 80.97M $ -78.83M PE Ratio